Trends in Biotechnology · Sep 3, 2026

Advancing European standards and regulations for 3D bioprinting

By Maddalon A, Leonetti G, Zimmer S

3D bioprinting has the potential to provide nonanimal alternatives to preclinical testing and revolutionize current clinical and transplantation practices. Realizing this potential requires a concerted effort to develop and advance European standards and regulatory frameworks, ensuring a clear and safe pathway for the clinical integration of 3D bioprinting.

doi.org/10.1016/j.tibtech.2026.08.001Open accessPubMed 42692932Industry & policy

AgingResearch.News